Scientists use PET scans to watch arthritis drug travel through Patients' bodies
NCT ID NCT07147959
Summary
This study aims to see where an experimental drug called CIT-013 goes in the body of people with inflammatory diseases like rheumatoid arthritis. Researchers will give patients a small, traceable amount of the drug and use PET-CT scans to track its movement to different organs and tissues. The goal is to understand how the drug distributes in the body to better evaluate its potential as a future treatment.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
NL-01
RECRUITINGNijmegen, Netherlands
Contact
Conditions
Explore the condition pages connected to this study.